Cadrenal Therapeutics (CVKD) Cash & Equivalents Growth (3y) (2025 - 2026)

Cadrenal Therapeutics (CVKD) Cash & Equivalents Growth (3y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-15.41%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	8.23%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	47.78%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-23.18%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	14.34%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	37.45%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-14.22%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-3.85%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-27.97%
10	Cadrenal Therapeutics	4.59 Mn	2.19 Mn	-	-9.42%

Download Data